Navigation Links
Nexavar Data to be Presented at 46th American Society of Clinical Oncology Annual Meeting
Date:5/20/2010

nd individual investigators as a single agent or as a combination treatment in a wide range of cancers, including lung, thyroid, breast, ovarian, and colorectal cancer and as an adjuvant therapy for liver and kidney cancer. 

Important Safety Considerations For Patients Taking Nexavar

Based on the currently approved U.S. package insert for the treatment of patients with unresectable hepatocellular carcinoma and advanced kidney cancer, hypertension may occur early in the course of therapy and blood pressure should be monitored weekly during the first six weeks of therapy and treated as needed.  In HCC patients, bleeding with a fatal outcome from any site was reported in 2.4% for Nexavar and 4% in placebo.  The incidence of treatment-emergent cardiac ischemia/infarction was 2.7% for Nexavar vs. 1.3% for placebo.  In RCC patients, incidence of bleeding regardless of causality was 15% for Nexavar vs. 8% for placebo and the incidence of treatment-emergent cardiac ischemia/infarction was 2.9% for Nexavar vs. 0.4% for placebo.  Most common adverse events >/=20% related to Nexavar for both HCC and RCC were fatigue, weight loss, rash/desquamation, hand-foot skin reaction, alopecia, diarrhea, nausea, and abdominal pain.  Grade 3/4 adverse events in HCC and RCC patients, respectively, were 45% for Nexavar vs. 32% for placebo and 38% for Nexavar and 28% for placebo.  Women of child-bearing potential should be advised to avoid becoming pregnant and advised against breast-feeding.  In cases of any severe or persistent side effects, temporary treatment interruption, dose modification or permanent discontinuation should be considered.

For information about Nexavar including U.S. Nexavar prescribing information, visit

SOURCE Bayer HealthCare Pharmaceuticals, Inc.; Onyx Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related biology technology :

1. Onyx Pharmaceuticals Announces a Teleconference and Webcast to Provide an Update on Nexavar and Report Full Year 2007 Financial Results
2. Bayer and Onyx Announce Nexavar Data Presentations at 44th American Society of Clinical Oncology Annual Meeting
3. Onyx Pharmaceuticals Announces a Teleconference and Webcast to Provide an Update on Nexavar
4. Bayer and Onyx Announce Nexavar Data Presentations at 45th American Society of Clinical Oncology Annual Meeting
5. Three Studies by Independent Scientists Highlighting Pressure Cycling Technology (PCT) to be Presented this Week at the British Mass Spectrometry Societys 29th Annual Meeting
6. Survival Data Presented From Phase II Study of Investigational Drug ZD4054 in Hormone-Resistant Prostate Cancer Patients
7. New Data Presented on Immunocytokine Fusion Protein Further Supports Broad Anti-Cancer Potential Of Peregrines Anti-PS Technology Platform
8. Results of Colon Cancer Study Utilizing Pressure Cycling Technology (PCT) Presented at the American College of Gastroenterology Annual Scientific Meeting
9. Kuvan, Naglazyme and Aldurazyme Data to Be Presented at the 57th Annual Meeting of the American Society of Human Genetics
10. Micromet Data Presented at the International AACR-NCI-EORTC Conference Support the Development of Adecatumumab (MT201) in Earlier Stage Cancer Disease Settings
11. Three PDX (Pralatrexate) Studies Presented at the 2007 AACR-NCI-EORTC Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/22/2014)... D.C (PRWEB) September 22, 2014 FierceBiotech ... top privately held biotechnology companies of 2014. FierceBiotech ... companies before selecting this year’s winners. Those selected ... biotechnology companies in the industry. , "It's ... new group of Fierce 15 companies," said Carroll. "This ...
(Date:9/22/2014)... 2014  Spherix Incorporated (SPEX) -- an intellectual property development ... today announced that the United States Patent & Trademark Office ... month of September that is part of a standard essential ... USRE45,121 , Application number: US 13/728,867 , ... 27, 2012 The listed inventors of the ...
(Date:9/20/2014)... 20, 2014 HealthTronics, Inc. ... interventional radiology products and services, has signed a ... Clinicon Corporation for its high precision ... of minimally invasive, mobile, surgical technology—offering more choices ... the agreement, HealthTronics will make available Clinicon’s FDA-cleared ...
(Date:9/19/2014)... that use light, rather than electricity, to move ... energy efficiency is a growing concern as chips, ... components of optical circuits light emitters, modulators, ... build. One promising light source for optical chips ... properties when deposited as a single, atom-thick layer. ...
Breaking Biology Technology:FierceBiotech Announces Annual “Fierce 15” Winners of 2014 2Spherix Notified by United States Patent & Trademark Office of New Standard Essential Patent Issued to Spherix 2Spherix Notified by United States Patent & Trademark Office of New Standard Essential Patent Issued to Spherix 3HealthTronics Announces Distribution Agreement with Clinicon-Laser Surgical Device Expands Minimally Invasive, Mobile Technology Portfolio 2HealthTronics Announces Distribution Agreement with Clinicon-Laser Surgical Device Expands Minimally Invasive, Mobile Technology Portfolio 3Toward optical chips 2Toward optical chips 3
... July 1 Pharmasset, Inc.,(Nasdaq: VRUS ) joined ... equity indexes on June 27., Pharmasset,s membership in ... means automatic inclusion in the small-cap Russell 2000(R) Index,as ... Russell indexes,are widely used by investment managers for index ...
... Inc. ("ChromaDex"),today announced that effective June 20, 2008, ... the wholly-owned subsidiary of Cody,Resources, Inc. ("Cody") (OTC ... wholly owned by a company whose shares are ... to meet the ongoing needs,of a rapidly growing ...
... and Ben Eynon Each Assume Vice President Roles at ... ... the,market and technology leader of nanopatterning systems and solutions, today,announced that ... industry veterans are assuming the roles of vice,president of marketing and ...
Cached Biology Technology:Pharmasset Joins Russell 3000 Index 2ChromaDex, Inc. Announces Completion of Reverse Merger With Cody Resources, Inc. 2Industry Veterans Join Molecular Imprints' Management Team 2Industry Veterans Join Molecular Imprints' Management Team 3
(Date:9/22/2014)... of cut grass in recent years has been identified ... research says the aroma also summons beneficial insects to ... the plant signals the environment via the emission of ... queue for parasitic wasps to come to the plant ... pest insect," said Dr. Michael Kolomiets, Texas A&M AgriLife ...
(Date:9/22/2014)... that manufacture their own "antifreeze" proteins to survive ... unfortunate side effect, researchers report: The protein-bound ice ... even when temperatures warm. , The finding ... National Academy of Sciences . , "We discovered ... the evolution of antifreeze proteins in Antarctic notothenioid ...
(Date:9/22/2014)... (September 22, 2014) Additive manufacturing (AM), or ... the production of complex-shaped metal components strong enough ... fewer errors and distortions, as well as quality ... kept pace with the technology. Engineers at the ... proposing to develop enhanced modeling and simulation (M&S) ...
Breaking Biology News(10 mins):Mown grass smell sends SOS for help in resisting insect attacks, researchers say 2Mown grass smell sends SOS for help in resisting insect attacks, researchers say 3Study: Antifreeze proteins in Antarctic fishes prevent freezingand melting 2Study: Antifreeze proteins in Antarctic fishes prevent freezingand melting 3Pitt engineers receive grants to enhance additive manufacturing 2Pitt engineers receive grants to enhance additive manufacturing 3
... Sower, professor of biochemistry and director of the Center ... New Hampshire, has received a $420,000 grant from the ... pituitary hormones and receptors. With the four-year ... research in the fields of hormonal genomics and proteomics. ...
... New software developed with help from the Wildlife ... individual animals by creating a three-dimensional model using photos ... an issue of the journal Biology Letters , ... confiscated skins. The new software, developed by Conservation Research ...
... 12, 2009) Researchers from DaVinci Biosciences, Costa Mesa, ... have determined that injecting a patient,s own bone marrow-derived ... using multiple routes can be an effective treatment for ... life for SCI patients without serious adverse events. Publishing ...
Cached Biology News:Major NSF grant boosts UNH research on hormonal genomics 2Tracking tigers in 3-D 2Multiple route bone marrow stem cell injections show promise to treat spinal cord injury 2
... the Flp-In System creates isogenic cell ... levels of the protein of interest. ... Figure 3 (click link below). In ... chloramphenicol-acetyl transferase (CAT) was subcloned into ...
... for molecular weight determinations for petroleum-based applications. Multiple solvents can be used, such as water, ... ... ... ...
Fast, sensitive quantitation of total MEK 1/2 concentration....
... and flexibility press-to-seal silicone isolators can be ... researcher. They are available either pre-cut to ... that can be easily trimmed to prepare ... non-cytotoxic and can be used to isolate ...
Biology Products: